DAVID M MARKOVITZ, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301053417
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301053417
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
1500 Floor Taubman Ctr, Ann Arbor, MI 48109
Phone
(734) 647-5899
(734) 936-2047
(734) 936-2047
Personal information
See more information about DAVID M MARKOVITZ at radaris.comName
Address
Phone
1415 Wells St, Ann Arbor, MI 48104
1415 Wells St, Ann Arbor, MI 48104
1500 Medical Center Dr, Ann Arbor, MI 48109
Professional information
See more information about DAVID M MARKOVITZ at trustoria.com
Dr. David M Markovitz, Ann Arbor MI - MD (Doctor of Medicine)
Dr. David M Markovitz, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
TAUBMAN CENTER RECP D
1500 E Medical Center Dr SUITE 5352, Ann Arbor 48109
(734) 647-5899 (Phone), (734) 615-2156 (Fax)
1500 E Medical Center Dr SUITE 5352, Ann Arbor 48109
(734) 647-5899 (Phone), (734) 615-2156 (Fax)
Certifications:
Infectious Disease, 1986, Internal Medicine, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
TAUBMAN CENTER RECP D
1500 E Medical Center Dr SUITE 5352, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr SUITE 5352, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
University of Mn Med Sch
Graduated: 1981
University of Mn Med Sch
Graduated: 1981
David M Markovitz, Ann Arbor MI
David M Markovitz, Ann Arbor MI
Specialties:
Infectious Disease Specialist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Minnesota, Medical School - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Novel Methods For Inhibition Of Hiv Replication
Novel Methods For Inhibition Of Hiv Replication
US Patent:
2003002, Feb 6, 2003
Filed:
Sep 20, 2001
Appl. No.:
09/961696
Inventors:
David Markovitz - Ann Arbor MI, US
Brian Lane - Ann Arbor MI, US
Peter Polverini - Falcon Heights MN, US
Robert Strieter - Sherman Oaks CA, US
Brian Lane - Ann Arbor MI, US
Peter Polverini - Falcon Heights MN, US
Robert Strieter - Sherman Oaks CA, US
International Classification:
A61K039/395, A61K038/17
US Classification:
424/144100, 514/002000
Abstract:
Methods are provided for inhibiting or suppressing viral replication in an infected host cell. More specifically, methods are provided for inhibiting or suppressing viral replication in an infected host cell by administering compounds that interfere with the binding of C-X-C chemokines to C-X-C chemokine receptors. Such methods are advantageous for treating viral infections such as human immunodefeciency virus infections.
Methods Of Inhibiting Host-Cell Mediated Viral Replication
Methods Of Inhibiting Host-Cell Mediated Viral Replication
US Patent:
2002013, Sep 26, 2002
Filed:
Jun 11, 2001
Appl. No.:
09/878541
Inventors:
David Markovitz - Ann Arbor MI, US
Neil Faulkner - Ypsilanti MI, US
Brian Lane - Ann Arbor MI, US
Neil Faulkner - Ypsilanti MI, US
Brian Lane - Ann Arbor MI, US
International Classification:
A61K048/00, A61K031/35
US Classification:
514/044000, 514/454000
Abstract:
Methods are provided for inhibiting or suppressing viral replication in an infected host cell. More specifically, methods are provided for inhibiting or suppressing viral replication in an infected host cell by administering compounds that inhibit cellular protein phosphatase 2A. Such methods are advantageous for treating viral infections such human immunodefeciency virus infections.
Methods Of Secretory Vimentin Detection And Modulation
Methods Of Secretory Vimentin Detection And Modulation
US Patent:
7691582, Apr 6, 2010
Filed:
Sep 24, 2003
Appl. No.:
10/670065
Inventors:
David M. Markovitz - Ann Arbor MI, US
Nirit Mor-Vaknin - Ann Arbor MI, US
Antonello Punturieri - Ann Arbor MI, US
Nirit Mor-Vaknin - Ann Arbor MI, US
Antonello Punturieri - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
G01N 33/53
US Classification:
435 71, 435 72, 435 732, 435325, 436501, 4241301
Abstract:
The present invention relates to methods for screening and modulating the bioavailability of extracellular secretory vimentin. In particular, the present invention provides inhibitors and activators of secretory vimentin including antibodies, small interfering RNAs, and antisense oligonucleotides. The present invention thus provides novel drug targets for enhanced anti-microbial response, and methods of using such modulators to beneficially alter the pathophysiologic effects of secretory vimentin.
Compositions And Methods For Detecting Cancer And For Inhibiting Metastasis
Compositions And Methods For Detecting Cancer And For Inhibiting Metastasis
US Patent:
7641902, Jan 5, 2010
Filed:
Nov 20, 2006
Appl. No.:
11/601895
Inventors:
David M. Markovitz - Ann Arbor MI, US
Nirit Mor-Vaknin - Ann Arbor MI, US
Evan T. Keller - Ann Arbor MI, US
Christopher L. Hall - Ypsilanti MI, US
Susan M. Hiniker - Ann Arbor MI, US
Nirit Mor-Vaknin - Ann Arbor MI, US
Evan T. Keller - Ann Arbor MI, US
Christopher L. Hall - Ypsilanti MI, US
Susan M. Hiniker - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/395
US Classification:
4241301, 5303871
Abstract:
The present invention relates to compositions and methods for detecting cancer (e. g. , prostate cancer) and for inhibiting metastasis (e. g. , associated with prostate cancer). In particular, the present invention provides methods of detecting vimentin expression and secretion and for characterizing cancer (e. g. , prostate cancer). In addition, the present invention provides methods for inhibiting metastasis (e. g. , of prostate cancer) via altering (e. g. , inhibiting) vimentin expression and/or activity.
Lectins And Uses Thereof
Lectins And Uses Thereof
US Patent:
2013009, Apr 18, 2013
Filed:
Apr 11, 2011
Appl. No.:
13/640498
Inventors:
David Markovitz - Ann Arbor MI, US
Michael Swanson - Ann Arbor MI, US
Irwin Goldstein - East Ann Arbor MI, US
Harry Winter - Ann Arbor MI, US
Michael Swanson - Ann Arbor MI, US
Irwin Goldstein - East Ann Arbor MI, US
Harry Winter - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C07K 14/42
US Classification:
514 24, 530370, 514 23, 514 37, 514 46, 514 33, 514 38, 4353201, 43525233
Abstract:
The present invention relates to chemical compounds, methods for their discovery, and their therapeutic and re-search use. In particular, the present invention provides antiviral and antimicrobial lectin compounds (BanLec) isolated from bananas. These compounds have low mitogenicity and pro-inflammatory activity whilst maintaining anti-HIV-1 activity.
Antiviral Treatment Of Lymphoma And Cancer
Antiviral Treatment Of Lymphoma And Cancer
US Patent:
2012013, May 31, 2012
Filed:
May 21, 2010
Appl. No.:
13/321416
Inventors:
Mark H. Kaplan - Ann Arbor MI, US
David Markovitz - Ann Arbor MI, US
David Markovitz - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 31/7072, A61K 31/7076, A61K 31/536, A61K 31/551, A61K 31/505, A61K 31/4418, A61K 31/427, A61K 31/635, A61K 31/496, A61P 35/00, C12Q 1/70, C40B 30/00, A61P 31/12, A61K 31/513, A61K 31/7068, A61K 31/52, A61K 31/708
US Classification:
514 45, 514 50, 514 81, 5142305, 514220, 514272, 514357, 514365, 514158, 51425301, 435 5, 506 7, 514274, 514 49, 5142634
Abstract:
Compositions and methods to treat lymphoma and cancer are disclosed. In particular, the method teaches treatment of lymphoma and cancer using anti-HERV-K(HML-2) therapies. Further taught are compositions and methods for characterizing patient samples to, for example, select or identify therapeutic options or assess the impact of therapies.
Dek Protein Compositions And Methods Of Using The Same
Dek Protein Compositions And Methods Of Using The Same
US Patent:
2009000, Jan 1, 2009
Filed:
Oct 16, 2006
Appl. No.:
12/090164
Inventors:
David A. Markovitz - Ann Arbor MI, US
Nirit Mor-Vaknin - Ann Arbor MI, US
Michael Khodadoust - Ann Arbor MI, US
Barbara S. Adams - Ann Arbor MI, US
Nirit Mor-Vaknin - Ann Arbor MI, US
Michael Khodadoust - Ann Arbor MI, US
Barbara S. Adams - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 39/395, A61K 31/7105, C12Q 1/68, G01N 33/535
US Classification:
4241411, 514 44, 4241301, 435 6, 435 792
Abstract:
The present invention relates to DEK protein compositions (e.g., antibodies, small molecule inhibitors, siRNAs) and methods of using the same. In particular, the present invention provides compositions and methods for treating autoimmune disease (e.g., juvenile rheumatoid arthritis, lupus, etc.) and for inhibiting inflammation (e.g., associated with autoimmune disease) and cellular chemotaxis (e.g., of neutrophils, NK cells and T cells). The present invention further provides a diagnostic marker (e.g., DEK antigen) for autoimmune disease.
Herv Group Ii Viruses In Lymphoma And Cancer
Herv Group Ii Viruses In Lymphoma And Cancer
US Patent:
2008026, Oct 23, 2008
Filed:
Sep 10, 2007
Appl. No.:
11/852369
Inventors:
David Markovitz - Ann Arbor MI, US
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - Setauket NY, US
Mark H. Kaplan - Ann Arbor MI, US
Michael H. Dosik - Setauket NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, G01N 33/574, C12Q 1/02
US Classification:
435 6, 435 723, 435 29
Abstract:
The present invention relates to compositions and methods for cancer diagnosis and therapy, including but not limited to, cancer markers. In particular, the present invention relates to HERV-K(HML-2) target titers as diagnostic markers, and HERV-K(HML-2) therapeutic targets for HIV-related cancers, and other cancers.